Image

Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study

Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study

Recruiting
13-18 years
All
Phase N/A

Powered by AI

Overview

The purpose of this translational bench-to-bedside study is to examine the neurobiological effects of an evidence-based technology-delivered mindfulness training (MT) program on vaping-related rsFC alterations in hippocampal networks and testing whether changes in rsFC ((Delta)rsFC) in these networks predict reduction in tobacco vaping behaviors in adolescents. The study also aims to test the accessibility and feasibility of using this mindfulness-based stress reduction (MBSR) platform as an implementation for widespread MT in adolescents....

Description

Study Description:

This protocol will use fMRI and in-person and technology-delivered mindfulness-based stress reduction (MBSR) training to elucidate neurobehavioral correlates of regular nicotine vaping in adolescents compared to non-vaping adolescents, and changes in these correlates after MBSR training. Our central hypothesis is that nicotine vaping in adolescents will be associated with impaired hippocampal connectivity with large-scale brain networks (e.g., Executive Control network (ECN), Default Mode Network (DMN), Salience Network (SN)) involved in cognitive control and emotion regulation and decreased state transitions (measured via dynamic resting state functional connectivity (rsFC)); and that MBSR training will increase hippocampal connectivity to ECN and alter time in state and state transitions in frequent vaping adolescents, with these rsFC changes predicting changes in vaping behavior.

Objectives

Primary Objectives:

  1. To characterize static and dynamic rsFC of hippocampal networks in frequent nicotine vaping adolescents compared to non-vaping adolescents.
  2. To characterize rsFC changes in hippocampal networks following an in-person and technology-delivered MBSR training program in frequent nicotine vaping adolescents.

Secondary Objectives:

  • To assess engagement with a smoking cessation app and changes in vaping behavior, emotion and cognition in the 3 months following MBSR training.
  • To assess differences between vaping and non-vaping teens pre- and post-MBSR training on other measures of network connectivity.
    Endpoints

Primary Endpoints:

  • (1) Seed-based rsFC between hippocampal seed regions and large-scale brain networks (DMN, ECN, SN) and dynamicrsFC measures in 40 nicotine vaping and 40 non-vaping youth.
  • (2) Seed-based rsFC between hippocampal seed regions and large-scale brain networks (DMN, ECN, SN) and dynamicrsFC measures within the nicotine vaping group Pre/Post MBSR training.

Secondary Endpoint:

  • Engagement with MBSR training and post-training Cravingto- Quit app and change scores for other behavioral measure (e.g. vaping, emotion regulation).
  • rsFC from seeds such as dorsal anterior cingulate.

Eligibility

  • INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

Non-Vaping group:

  1. For adolescents aged 17 and under, parental/guardian informed consent to participate in the study
  2. English language fluency
  3. Males and females; Age 13-18 enrolled in grades 9-12.
  4. No MRI contraindications
  5. No evidence of current psychosis, mania, or significant suicidality
  6. If on medication for depression, anxiety or ADHD, dose has been stable for 3 months
  7. No DSM-5 diagnosis of moderate or severe SUD related to a psychoactive substance, including tobacco, in the past year
  8. Access to necessary resources for participating in a technology-based intervention, which includes smartphone ownership for this study
  9. No use of nicotine more than 5 times in their life, and none at all in the last 30 days prior to enrollment.

Vaping group:

  1. For adolescents aged 17 and under, parental/guardian informed consent to participate in the study
  2. English language fluency
  3. Males and females; Age 13-18 enrolled in grades 9-12.
  4. No MRI contraindications
  5. No evidence of current psychosis, mania, or significant suicidality
  6. If on medication for depression, anxiety or ADHD, dose has been stable for 3 months
  7. No DSM-5 diagnosis of moderate or severe SUD related to another psychoactive substance (other than tobacco) in the past year
  8. Vape a nicotine containing product at least 10 days in the past 30 days
  9. Access to necessary resources for participating in a technology-based intervention, which includes smartphone ownership for this study

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study based on self and or parent-report unless otherwise noted:

Vaping or Non-Vaping Group:

  1. Chronic medical conditions associated with cerebral blood flow abnormalities per PI/MAI determination after review of the medical history.
  2. Neurological conditions that may interfere with MRI data quality per PI/MAI determination after review of the medical history.
  3. Neurodevelopmental disorders that are likely to significantly affect data in the judgment of the MAI/PI
  4. Non-penetrating traumatic brain injury with loss of consciousness > 30 minutes or significant sequalae persisting longer than 2 weeks or any penetrating traumatic brain injury.
  5. Changing dose of psychotropic medication in past 3 months
  6. Current regular meditation or yoga practice averaging >10 min/day for >2 days per week
  7. Pregnancy, self-report upon protocol entry, but by urine test prior to MRI scan.

Study details
    Vaping Teens
    Healthy Volunteers

NCT06503159

National Institute on Drug Abuse (NIDA)

1 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.